{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:35Z","timestamp":1760775035085,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001043","name":"Cass Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bmcl.2021.127813","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T22:32:43Z","timestamp":1611268363000},"page":"127813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of an automated assay for accelerated in vitro detection of DNA adduct-inducing and crosslinking agents"],"prefix":"10.1016","volume":"35","author":[{"given":"Jelena","family":"Medan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad E.","family":"Sleebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Lackovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith G.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny J.","family":"Evison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don R.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Cutts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bmcl.2021.127813_b0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.hfc.2011.03.001","article-title":"A Historical perspective of anthracycline cardiotoxicity","volume":"7","author":"Ewer","year":"2011","journal-title":"Heart Failure Clin"},{"issue":"2","key":"10.1016\/j.bmcl.2021.127813_b0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/med.21364","article-title":"Mitoxantrone, More than just another topoisomerase II poison: mitoxantrone, more than just a topoisomerase II poison","volume":"36","author":"Evison","year":"2016","journal-title":"Med Res Rev"},{"issue":"8","key":"10.1016\/j.bmcl.2021.127813_b0015","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1021\/acs.chemrestox.6b00190","article-title":"Rethinking drugs from chemistry to therapeutic opportunities: pixantrone beyond anthracyclines","volume":"29","author":"Menna","year":"2016","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.bmcl.2021.127813_b0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0026-895X(25)10042-4","article-title":"Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives","volume":"48","author":"De Isabella","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"14","key":"10.1016\/j.bmcl.2021.127813_b0025","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2174\/1568026615666150413154512","article-title":"Potential therapeutic advantages of doxorubicin when activated by formaldehyde to function as a DNA adduct-forming agent","volume":"15","author":"Cutts","year":"2015","journal-title":"Curr Top Med Chem"},{"issue":"19","key":"10.1016\/j.bmcl.2021.127813_b0030","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1021\/jm901894c","article-title":"New anthracenedione derivatives with improved biological activity by virtue of stable Drug\u2212DNA adduct formation","volume":"53","author":"Mansour","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127813_b0035","doi-asserted-by":"crossref","unstructured":"Evison, B.J., et al., Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent. Nucleic Acids Research, 2007. 35(11): p. 3581-3589.","DOI":"10.1093\/nar\/gkm285"},{"issue":"20","key":"10.1016\/j.bmcl.2021.127813_b0040","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1073\/pnas.95.20.11561","article-title":"Characterization of covalent adriamycin-DNA adducts","volume":"95","author":"Zeman","year":"1998","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.bmcl.2021.127813_b0045","first-page":"1125","article-title":"Production of formaldehyde from N5-methyltetrahydrofolate by normal and leukemic leukocytes","volume":"37","author":"Thorndike","year":"1977","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.bmcl.2021.127813_b0050","first-page":"8194","article-title":"Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9)","volume":"61","author":"Cutts","year":"2001","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.bmcl.2021.127813_b0055","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1158\/0008-5472.CAN-05-3410","article-title":"Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II\u2013Mediated Form of Cell Death","volume":"66","author":"Swift","year":"2006","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.bmcl.2021.127813_b0060","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/jm960835d","article-title":"Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin","volume":"40","author":"Taatjes","year":"1997","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2021.127813_b0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1124\/mol.108.045625","article-title":"Formaldehyde-activated pixantrone is a monofunctional DNA alkylator that binds selectively to CpG and CpA doublets","volume":"74","author":"Evison","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"18","key":"10.1016\/j.bmcl.2021.127813_b0070","doi-asserted-by":"crossref","first-page":"18814","DOI":"10.1074\/jbc.M400931200","article-title":"A molecular understanding of mitoxantrone-DNA adduct formation","volume":"279","author":"Parker","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2021.127813_b0075","doi-asserted-by":"crossref","unstructured":"Murray, V., T.V. Nguyen, and J.K. Chen, The use of automated sequencing techniques to investigate the sequence selectivity of DNA-damaging agents. Chem Biol Drug Des, 2012. 80(1): p. 1-8.","DOI":"10.1111\/j.1747-0285.2012.01379.x"},{"key":"10.1016\/j.bmcl.2021.127813_b0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-60327-418-0_13","article-title":"In vitro transcription assay for resolution of drug-DNA interactions at defined DNA sequences","volume":"613","author":"Evison","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmcl.2021.127813_b0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-61779-421-6_10","article-title":"(3)(2)P-postlabelling for the sensitive detection of DNA adducts","volume":"817","author":"Jones","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmcl.2021.127813_b0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-60327-418-0_18","article-title":"Measurement of DNA interstrand crosslinking in naked DNA using gel-based methods","volume":"613","author":"Kiakos","year":"2010","journal-title":"Methods Mol Biol"},{"issue":"41","key":"10.1016\/j.bmcl.2021.127813_b0095","doi-asserted-by":"crossref","first-page":"13303","DOI":"10.1021\/bi960306b","article-title":"DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the caribbean tunicate ecteinascidia turbinata","volume":"35","author":"Pommier","year":"1996","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bmcl.2021.127813_b0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2012.08.007","article-title":"The analysis of DNA adducts: the transition from 32P-postlabeling to mass spectrometry","volume":"334","author":"Klaene","year":"2013","journal-title":"Cancer Lett"},{"issue":"27","key":"10.1016\/j.bmcl.2021.127813_b0105","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1021\/ja994192d","volume":"122","author":"Boger","year":"2000","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.bmcl.2021.127813_b0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ab.2009.10.031","article-title":"Optimization of time-resolved fluorescence assay for detection of europium\u2013tetraazacyclododecyltetraacetic acid-labeled ligand\u2013receptor interactions","volume":"398","author":"De Silva","year":"2010","journal-title":"Anal Biochem"},{"issue":"6","key":"10.1016\/j.bmcl.2021.127813_b0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1021\/bc000112f","article-title":"A derivative of diethylenetriaminepentaacetic acid for europium labeling of proteins","volume":"12","author":"Lee","year":"2001","journal-title":"Bioconjugate Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2021.127813_b0120","doi-asserted-by":"crossref","first-page":"115260","DOI":"10.1016\/j.bmc.2019.115260","article-title":"Formaldehyde-activated WEHI-150 induces DNA interstrand crosslinks with unique structural features","volume":"28","author":"Pumuye","year":"2020","journal-title":"Bioorg Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:38:01Z","timestamp":1760773081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":24,"alternative-id":["S0960894X21000391"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127813","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an automated assay for accelerated in vitro detection of DNA adduct-inducing and crosslinking agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127813"}}